Read about recent events, essential information and the latest community news.
Developed by ISCT Business Development & Finance Committee The year 2025 marked a notable period of momentum for the cell and gene therapy (CGT) sector, characterised by significant deal making across Read more...
Fajar Dumadi, BSc International Society for Cell & Gene Therapy (ISCT) Canada Following the release of the latest edition of the ISCT CGT Global Regulatory Report —presenting a comprehensive year-end Read more...
Tuula Rintala Director, Quality of Care and Advocacy EBMT, European Society for Blood and Marrow Transplantation Spain CAR-T cell therapy has transformed the treatment landscape for patients with Read more...
Introduction In the rapidly evolving landscape of advanced therapies, few challenges are as complex — or as consequential — as scaling cell therapy manufacturing to meet growing clinical and commercial Read more...
Madhavi Lakkaraja, MD, MPH Fred Hutchinson Cancer Center, University of Washington School of Medicine United States From ISCT 2025 Roundtable Session: Cell Therapies to Manage GVHD - Learning From Read more...
Hannah Song, PhD Contributing Editor, ISCT Telegraft National Institutes of Health United States It is my great honor and privilege to write to you today as a newly-minted Telegraft Editorial Read more...
Medhat Askar, MD, PhD, MSHPE, FRCPath Member, ISCT Lab Practices Committee Texas A&M College of Medicine United States Rajdeep Das, MD, PhD, FIBMS Member, ISCT Lab Practices Committee University Hospitals Read more...
Shyam Bhakta, MD, MBA Contributing Editor, ISCT Telegraft United States Dr. Mary Laughlin grew up in Buffalo, NY, where the Roswell Park Cancer Center and Institute is located and where she also completed Read more...
Advanced therapy development is no longer limited by whether the science can work. Platform technologies are established, translational pathways are better understood, and the distance between discovery Read more...
ISCT Mesenchymal Stromal Cell (MSC) Committee Mesenchymal stromal cells (MSCs) are among the most widely used cellular products worldwide, yet the field still lacks shared, testable answers about Read more...